Efficacy of small-volume plasmapheresis application for MDR/XDR TB patients with medicinal live damag?
A. Samoilova (Moscow, Russian Federation), E. Vaniev (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Disease area: Respiratory infections
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Samoilova (Moscow, Russian Federation), E. Vaniev (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation). Efficacy of small-volume plasmapheresis application for MDR/XDR TB patients with medicinal live damag?. 525
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: